Roseola

WikiDoc Resources for Roseola
Articles
Most recent articles on Roseola Most cited articles on Roseola Review articles on Roseola Articles on Roseola in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Roseola Images of Roseola Photos of Roseola Podcasts & MP3s on Roseola Videos on Roseola
Evidence Based Medicine
Cochrane Collaboration on Roseola Bandolier on Roseola TRIP on Roseola
Clinical Trials
Ongoing Trials on Roseola at Clinical Trials.gov Trial results on Roseola Clinical Trials on Roseola at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Roseola NICE Guidance on Roseola NHS PRODIGY Guidance FDA on Roseola CDC on Roseola
Books
Books on Roseola
News
Roseola in the news Be alerted to news on Roseola News trends on Roseola
Commentary
Blogs on Roseola
Definitions
Definitions of Roseola
Patient Resources / Community
Patient resources on Roseola Discussion groups on Roseola Patient Handouts on Roseola Directions to Hospitals Treating Roseola Risk calculators and risk factors for Roseola
Healthcare Provider Resources
Symptoms of Roseola Causes & Risk Factors for Roseola Diagnostic studies for Roseola Treatment of Roseola
Continuing Medical Education (CME)
CME Programs on Roseola
International
Roseola en Espanol Roseola en Francais
Business
Roseola in the Marketplace Patents on Roseola
Experimental / Informatics
List of terms related to Roseola

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Exanthem subitum (meaning sudden rash), also referred to as roseola infantum (or rose rash of infants), sixth disease (as the sixth rash-causing childhood disease) and (confusingly) baby measles, or three day fever, is a benign disease of children, generally under two years old, whose manifestations are usually limited to a transient rash ("exanthem") that occurs following a fever of about three day's duration.

Until recently, its origin was unknown, but it is now known to be caused by two human herpesviruses, HHV-6 (Human Herpesvirus Six) and HHV-7, also called Roseolovirus.

Clinical Features

[[ File:Roseola rash.jpg|200px|thumb|none|Roseola on a 21-month-old girl]]

Typically the disease affects a child between six months and three years of age, and begins with a sudden high fever of 102-104 degrees Fahrenheit (39-40 degrees Celsius). This can cause, in some cases, febrile convulsions (also known as febrile seizures or "fever fits") due to the sudden rise in body temperature, but in many cases the child appears and acts normal. After a few days the fever subsides, and just as the child appears to be recovering, a red rash appears. This usually begins on the trunk, spreading to the limbs but usually not affecting the face. It disappears again in a matter of hours to a day or so. In contrast, a child suffering from measles would usually appear more infirm, with symptoms of conjunctivitis and a cough, and their rash would affect the face and last for several days. Liver dysfunction can occur in rare cases, and the rare adult who contracts the disease can show signs of mononucleosis.

Vaccines and Treatment

There is no specific vaccine against or treatment for exanthem subitum, and most children with the disease are not seriously ill. A child with fever should be given plenty of fluids to drink, and paracetamol/acetaminophen or ibuprofen to reduce their temperature (but never aspirin, due to the risk of Reye's Syndrome). He or she should also be kept more lightly clothed than normal if he or she is very hot. The rash is not particularly itchy and needs no special lotions or creams.

It is likely that many children acquire exanthem subitum "subclinically"; in other words, they show no outward sign of the disease. Others may be debilitated enough that a doctor's opinion is required to confirm the diagnosis, and particularly to rule out other more serious infections, such as meningitis or measles. In case of febrile seizures, medical advice is essential.

• Human herpesvirus 7 (roseola virus) treatment

• Preferred regimen: Supportive therapy
• Note (1): Immunocompetent hosts with uncomplicated skin manifestations associated with HHV-7, particularly roseola infantum and pityriasis rosea, need only symptomatic management
• Note (2): For HIV-positive patients, antiretroviral therapy may be advisable
• Note (3): The most active antiviral compounds against HHV-7 are Cidofovir and Foscarnet

Gallery

• 
  14 month old infant manifested a non-specific rash in the form of extensive erythematous patches over his entire body. From Public Health Image Library (PHIL).
• 
  “Roseola rash” developed on syphilis patient buttocks and legs during the secondary stage of the disease. From Public Health Image Library (PHIL).
• Face and back of a young child after receiving a smallpox vaccination in the right shoulder region. From Public Health Image Library (PHIL). [5]
  Face and back of a young child after receiving a smallpox vaccination in the right shoulder region. From Public Health Image Library (PHIL).
• After smallpox vaccination, this 14 month old infant manifested a non-specific rash in the form of extensive erythematous patches over his entire body. From Public Health Image Library (PHIL). [5]
  After smallpox vaccination, this 14 month old infant manifested a non-specific rash in the form of extensive erythematous patches over his entire body. From Public Health Image Library (PHIL).

External links

• MedlinePlus encyclopedia entry on "roseola"
• Links to roseola pictures, Hardin MD/Univ of Iowa
• Newly Found Herpes Virus Is Called Major Cause of Illness in Young, New York Times
• HHV-6 Foundation
• Template:DermNet